• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

向患有镰状细胞性状的新生儿父母提供遗传风险信息:全科医生在新生儿筛查中的作用。

Providing genetic risk information to parents of newborns with sickle cell trait: role of the general practitioner in neonatal screening.

作者信息

Vansenne Fleur, de Borgie Corianne A J M, Legdeur Monica, Spauwen Marjo Oey, Peters Marjolein

机构信息

Department of Clinical Epidemiology, Biostatistics and Bioinformatics, University of Amsterdam, Amsterdam, The Netherlands.

出版信息

Genet Test Mol Biomarkers. 2011 Oct;15(10):671-5. doi: 10.1089/gtmb.2010.0232. Epub 2011 May 16.

DOI:10.1089/gtmb.2010.0232
PMID:21574852
Abstract

PURPOSE

In 2007, the neonatal screening program in the Netherlands was expanded to include hemoglobinopathies. Newborns with sickle cell disease (SCD), as well as SCD carriers are identified. The benefit of reporting SCD carriers includes detection of more couples at risk (both parents are carriers) who can be informed about future reproductive choices, a responsibility of their general practitioner (GP). We evaluated knowledge, ideas, and actions of GPs after reporting SCD carriers and explored and analyzed potential barriers.

METHODS

A questionnaire study.

RESULTS

A total of 139 GPs responded to our questionnaire (49%). Ninety GPs (90%) stated they informed parents of the test result. In only 23 cases (23%) both parents had themselves tested for hemoglobinopathies. Eighty-one GPs (64%) stated that they did not have enough clinical experience with SCD. Almost half of the GPs indicated that they did not experience any barriers in counseling patients (n=60, 48%).

CONCLUSION

At the moment, the goal of the neonatal screening for SCD carriers has not been achieved as the majority of parents were not tested for hemoglobinopathies after disclosure of carrier status in their newborn. With GPs reporting few barriers in counseling parents and only indicating a lack of knowledge and clinical experience, more effort is required to provide better information to GPs to help facilitate their work.

摘要

目的

2007年,荷兰的新生儿筛查项目扩大到包括血红蛋白病。镰状细胞病(SCD)新生儿以及SCD携带者得以被识别。报告SCD携带者的益处包括发现更多有风险的夫妇(父母双方均为携带者),这些夫妇可被告知未来的生育选择,这是他们的全科医生(GP)的一项职责。我们评估了全科医生报告SCD携带者后的知识、想法和行动,并探讨和分析了潜在障碍。

方法

一项问卷调查研究。

结果

共有139名全科医生回复了我们的问卷(回复率49%)。90名全科医生(90%)表示他们告知了父母检测结果。只有23例(23%)父母双方都进行了血红蛋白病检测。81名全科医生(64%)表示他们对SCD没有足够的临床经验。几乎一半的全科医生表示他们在为患者提供咨询时没有遇到任何障碍(n = 60,48%)。

结论

目前,SCD携带者新生儿筛查的目标尚未实现,因为在告知其新生儿携带者状态后,大多数父母并未进行血红蛋白病检测。由于全科医生表示在为父母提供咨询时障碍很少,只是表明缺乏知识和临床经验,因此需要做出更多努力,为全科医生提供更好的信息,以帮助促进他们的工作。

相似文献

1
Providing genetic risk information to parents of newborns with sickle cell trait: role of the general practitioner in neonatal screening.向患有镰状细胞性状的新生儿父母提供遗传风险信息:全科医生在新生儿筛查中的作用。
Genet Test Mol Biomarkers. 2011 Oct;15(10):671-5. doi: 10.1089/gtmb.2010.0232. Epub 2011 May 16.
2
[Information for parents of children with sickle cell trait detected by neonatal screening: A 10-year experience].[新生儿筛查发现镰状细胞性状患儿家长的信息:十年经验]
Arch Pediatr. 2015 May;22(5):562-3. doi: 10.1016/j.arcped.2015.02.020. Epub 2015 Apr 1.
3
After the introduction into the national newborn screening program: who is receiving genetic counseling for hemoglobinopathies in the Netherlands?纳入国家新生儿筛查项目后:荷兰哪些人正在接受血红蛋白病的遗传咨询?
Public Health Genomics. 2014;17(1):16-22. doi: 10.1159/000355223. Epub 2013 Nov 8.
4
Disclosing to parents newborn carrier status identified by routine blood spot screening.向父母披露通过常规血斑筛查确定的新生儿携带者状态。
Cochrane Database Syst Rev. 2004 Oct 18;2004(4):CD003859. doi: 10.1002/14651858.CD003859.pub2.
5
General practitioner attitudes to direct-to-consumer genetic testing in New Zealand.新西兰全科医生对直接面向消费者的基因检测的态度。
N Z Med J. 2012 Oct 26;125(1364):14-26.
6
Informing parents of newborns with sickle cell trait detected at neonatal screening: A northern France experience.新生儿镰状细胞特征筛查检出后告知父母:法国北部的经验。
Pediatr Blood Cancer. 2024 Oct;71(10):e31174. doi: 10.1002/pbc.31174. Epub 2024 Jul 8.
7
Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening.德国西南部镰状细胞病的显著流行:一项出生队列研究结果表明新生儿筛查的必要性。
Ann Hematol. 2016 Feb;95(3):397-402. doi: 10.1007/s00277-015-2573-y. Epub 2015 Dec 12.
8
Prevalence of Sickle Cell Trait and Reliability of Self-Reported Status among Expectant Parents in Nigeria: Implications for Targeted Newborn Screening.尼日利亚准父母中镰状细胞性状的患病率及自我报告状况的可靠性:对新生儿靶向筛查的影响
Public Health Genomics. 2016;19(5):298-306. doi: 10.1159/000448914. Epub 2016 Sep 10.
9
Neonatal screening and genetic counseling for sickle cell trait.镰状细胞性状的新生儿筛查与遗传咨询。
Am J Dis Child. 1985 Mar;139(3):241-4. doi: 10.1001/archpedi.1985.02140050035016.
10
A pilot study to explore knowledge, attitudes, and beliefs about sickle cell trait and disease.一项探索关于镰状细胞特质和疾病的知识、态度和信念的初步研究。
J Natl Med Assoc. 2009 Nov;101(11):1163-72. doi: 10.1016/s0027-9684(15)31113-5.

引用本文的文献

1
General practitioners' (GPs) experience, attitudes and needs on clinical genetic services: a systematic review.全科医生(GP)对临床遗传服务的经验、态度和需求:系统评价。
Fam Med Community Health. 2022 Nov;10(4). doi: 10.1136/fmch-2021-001515.
2
Characteristics associated with the perceived likelihood to become parents among young adults with sickle cell disease or sickle cell trait in the USA.美国年轻镰状细胞病或镰状细胞特征患者成为父母的可能性与哪些因素有关。
J Genet Couns. 2022 Jun;31(3):689-697. doi: 10.1002/jgc4.1535. Epub 2021 Nov 26.
3
Sickle cell trait newborn screen results: disclosure and management.
镰状细胞性状新生儿筛查结果:告知与管理。
J Community Genet. 2021 Jan;12(1):137-142. doi: 10.1007/s12687-020-00489-x. Epub 2020 Oct 26.
4
An Evaluation of Three Ways of Communicating Carrier Status Results to the Parents of Children in a Neonatal Sickle Cell Screening Programme.对新生儿镰状细胞筛查项目中向儿童家长传达携带者状态结果的三种方式的评估。
Front Pediatr. 2020 Jun 19;8:300. doi: 10.3389/fped.2020.00300. eCollection 2020.
5
A qualitative study to explore how professionals in the United Kingdom make decisions to test children for a sickle cell carrier status.一项定性研究,旨在探究英国的专业人员如何做出对儿童进行镰状细胞携带者状态检测的决策。
Eur J Hum Genet. 2016 Feb;24(2):164-70. doi: 10.1038/ejhg.2015.104. Epub 2015 May 27.
6
Disparities in current and future childhood and newborn carrier identification.当前及未来儿童和新生儿携带者识别方面的差异。
J Genet Couns. 2014 Oct;23(5):701-7. doi: 10.1007/s10897-014-9740-5. Epub 2014 Jul 11.
7
The attitudes and intention to participate in hemoglobinopathy carrier screening in The Netherlands among individuals from Turkish, Moroccan, and Surinamese descent.荷兰裔土耳其人、摩洛哥人和苏里南人参与血红蛋白病携带者筛查的态度和意愿。
J Environ Public Health. 2013;2013:374831. doi: 10.1155/2013/374831. Epub 2013 Nov 17.
8
Attitudes of general practitioners and midwives towards ethnicity-based haemoglobinopathy-carrier screening.全科医生和助产士对基于种族的血红蛋白病携带者筛查的态度。
Eur J Hum Genet. 2012 Nov;20(11):1112-7. doi: 10.1038/ejhg.2012.72. Epub 2012 May 2.